FGFR Mutations

#urothelial #fgfr #pathogenesis #frcpath #neetiniПодробнее

discovery of KIN-3248, a pan-FGFR inhibitorПодробнее

FGFR Symposium 2024: Part 2Подробнее

Discover how the FGFR2 gene influences cell behaviour and its link to cancer when mutated. #FGFR2Подробнее

Expansion cohort results of RAGNAR: erdafitinib in CCA with FGFR alterationsПодробнее

Day 3 - acquired resistance to FGFR inhibitorsПодробнее

Mutations activatrices de FGFR2 et anomalies de formation/réparation osseuse par le Dr Anne MoriceПодробнее

What are FGFR Genes?Подробнее

Phase II Study of Erdafitinib in Tumors with FGFR Amplifications and Mutations or FusionsПодробнее

What are FGFR Inhibitors?Подробнее

Fibroblast Growth Factor Receptor | FGFR | Mutations In FGFR |Подробнее

Webinar: Targeting the FGFR pathway: Infigratinib in cholangiocarcinomaПодробнее

Lec 15: The Biology of Cancer Growth Factor ReceptorПодробнее

Webinar: First-in Human-Studies of FGFR Inhibitor KIN-3248 and RAF Inhibitor KIN-2787Подробнее

The latest in bladder cancer with FGFR 2 and 3 mutationsПодробнее

Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bla...Подробнее

Final results from FIGHT-202: pemigatinib for patients with FGFR-mutated advanced cholangiocarcinomaПодробнее

Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With Targeted StrategiesПодробнее

FGFR InhibitorsПодробнее